These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21570653)

  • 21. Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).
    Capristo E; Miele L; Forgione A; Vero V; Farnetti S; Mingrone G; Greco AV; Gasbarrini G; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):265-8. PubMed ID: 16231587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
    Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.
    Anty R; Iannelli A; Patouraux S; Bonnafous S; Lavallard VJ; Senni-Buratti M; Amor IB; Staccini-Myx A; Saint-Paul MC; Berthier F; Huet PM; Le Marchand-Brustel Y; Gugenheim J; Gual P; Tran A
    Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1315-22. PubMed ID: 21050233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Zimmermann A; Grigorescu-Sido P; AlKhzouz C; Patberg K; Bucerzan S; Schulze E; Zimmermann T; Rossmann H; Geiss HC; Lackner KJ; Weber MM
    Horm Res Paediatr; 2010; 74(1):41-9. PubMed ID: 20395657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.
    Dumas ME; Kinross J; Nicholson JK
    Gastroenterology; 2014 Jan; 146(1):46-62. PubMed ID: 24211299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis.
    Musso G; Gambino R; De Michieli F; Cassader M; Rizzetto M; Durazzo M; Fagà E; Silli B; Pagano G
    Hepatology; 2003 Apr; 37(4):909-16. PubMed ID: 12668986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes.
    Mojiminiyi OA; Marouf R; Abdella NA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):559-66. PubMed ID: 18063352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease.
    Musso G; Gambino R; Durazzo M; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Rabbione L; Premoli A; Cassader M; Pagano G
    Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology of nonalcoholic fatty liver disease.
    Yeh MM; Brunt EM
    Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nonalcoholic steatohepatitis. Three case reports].
    Eivindson MV; Hamilton-Dutoit S; Grønbaek H
    Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.
    Chalasani N; Deeg MA; Persohn S; Crabb DW
    Am J Gastroenterol; 2003 Aug; 98(8):1849-55. PubMed ID: 12907343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
    Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
    J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
    Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
    Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Tarantino G; Saldalamacchia G; Conca P; Arena A
    J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Some parameters of carbohydrate and lipid metabolism in patients with non-alcoholic steatohepatitis].
    Mansurov KhKh; Mansurova FKh; Avezov SA; Khuzhamuratov MKh; Mirzoeva PF; Odinaev RI
    Klin Med (Mosk); 2005; 83(6):47-50. PubMed ID: 16075645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
    Peppa M; Boutati E; Koliaki C; Papaefstathiou N; Garoflos E; Economopoulos T; Hadjidakis D; Raptis SA
    Metabolism; 2010 Oct; 59(10):1435-41. PubMed ID: 20153874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is non alcoholic steatohepatitis (NASH) part of the metabolic syndrome?].
    Fehér J; Németh E; Lengyel G
    Orv Hetil; 2004 Jul; 145(29):1499-506. PubMed ID: 15453020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.